| WKN: | 924801 |
| ISIN: | US09061G1013 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die BioMarin Pharmaceutical-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 11. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2007 | 12,35 | 24,70 | 100,00% |
| 2 | 2005 | 4,58 | 8,85 | 93,23% |
| 3 | 2010 | 12,93 | 20,69 | 60,02% |
| 4 | 2014 | 50,25 | 75,70 | 50,65% |
| 5 | 2001 | 10,00 | 14,80 | 48,00% |
| 6 | 2006 | 8,85 | 12,35 | 39,55% |
| 7 | 2012 | 26,31 | 36,51 | 38,77% |
| 8 | 2013 | 36,51 | 50,25 | 37,63% |
| 9 | 2011 | 20,69 | 26,31 | 27,16% |
| 10 | 2015 | 75,70 | 95,18 | 25,73% |
| 11 | 2022 | 78,98 | 95,65 | 21,11% |
| 12 | 2021 | 70,13 | 78,98 | 12,62% |
| 13 | 2009 | 12,15 | 12,93 | 6,42% |
| 14 | 2003 | 5,90 | 6,20 | 5,08% |
| 15 | 2026 | 50,74 | 53,10 | 4,65% |
| 16 | 2019 | 72,74 | 75,91 | 4,36% |
| 17 | 2018 | 75,09 | 72,74 | -3,13% |
| 18 | 2017 | 78,88 | 75,09 | -4,80% |
| 19 | 2020 | 75,91 | 70,13 | -7,61% |
| 20 | 2023 | 95,65 | 87,66 | -8,35% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2002 | 14,80 | 5,90 | -60,14% |
| 2 | 2008 | 24,70 | 12,15 | -50,81% |
| 3 | 2024 | 87,66 | 64,02 | -26,97% |
| 4 | 2004 | 6,20 | 4,58 | -26,13% |
| 5 | 2025 | 64,02 | 50,74 | -20,74% |
| 6 | 2016 | 95,18 | 78,88 | -17,13% |
| 7 | 2023 | 95,65 | 87,66 | -8,35% |
| 8 | 2020 | 75,91 | 70,13 | -7,61% |
| 9 | 2017 | 78,88 | 75,09 | -4,80% |
| 10 | 2018 | 75,09 | 72,74 | -3,13% |
| 11 | 2019 | 72,74 | 75,91 | 4,36% |
| 12 | 2026 | 50,74 | 53,10 | 4,65% |
| 13 | 2003 | 5,90 | 6,20 | 5,08% |
| 14 | 2009 | 12,15 | 12,93 | 6,42% |
| 15 | 2021 | 70,13 | 78,98 | 12,62% |
| 16 | 2022 | 78,98 | 95,65 | 21,11% |
| 17 | 2015 | 75,70 | 95,18 | 25,73% |
| 18 | 2011 | 20,69 | 26,31 | 27,16% |
| 19 | 2013 | 36,51 | 50,25 | 37,63% |
| 20 | 2012 | 26,31 | 36,51 | 38,77% |